Ultrasonography of peritoneal tuberculosis

Mbengue, Ababacar; Ar, Ndiaye; Ni, Amar; Diallo, Mamadou Alpha; Diack, Aminata; Ndao,; Diop, Moustapha; Fall, A.; Ct, Diouf; To, Soko; Diakhaté, I.C.

doi:10.15557/jou.2019.0014

Cited by 11 publications

(9 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 Before this, a handful of Senegalese purchased the less effective pegylated interferon abroad or in downtown Dakar, at the country's best-stocked private pharmacy. HEPADAK subjects were enrolled by specialists in four Dakar hospitals and private clinics (Vray et al, 2006), who were referred as HBV infected individuals by major blood banks. Confronted with difficulties in using biopsy to assess liver damage, project researchers negotiated additional funding to purchase and evaluate a trademarked liver ultrasonograph, a portable and noninvasive imaging technology, in Dakar (Mbaye et al, 2011).…”

Section: Resultsmentioning

confidence: 99%

Filtering Inequality: Screening and Knowledge in Senegal’s Topography of Hepatitis B Care

Tousignant

2021

Front. Pharmacol.

View full text Add to dashboard Cite

Only a fraction of the estimated tenth or so of Senegalese who are chronically infected with hepatitis B virus (HBV) have been diagnosed. Of these, few have been assessed for their risk of progressing to potentially fatal liver disease (indicating need for treatment), and fewer still are taking antiviral drugs. A massive gap between those needing and getting treatment is widely acknowledged among experts. But given that HBV and its biomedical treatment options are largely invisible in bodies, health data, care practices, public messaging, or mass media, how can we observe, ethnographically, the effects of constraints on and inequalities in treatment? What are the stakes of access to drugs, when this access is not being sought out, claimed, or enacted? This article tackles these questions by examining how HBV is being enacted in Senegal, but not necessarily in relation to antiviral treatment. I first describe the emergence, over the past decade and a half, of an exclusionary topography of HBV diagnosis and treatment. I introduce the notion of “filtration” to describe the effects of this topography on the formation of potential “subjects of access.” The diagnostic therapies and expertise required to determine need for treatment are expensive, urban, and largely privatized. Moreover, knowledge about HBV and its possibilities of care circulates in narrow and sparsely distributed channels. Only a tiny minority of persons are effectively “filtered into” care, while issues of access remain largely outside of public debate. I then move onto small-scale efforts, led by rural primary health workers and community associations, to raise awareness of and expand screening for HBV. Those driving information and screening either do not reveal that effective drugs exist or locate these beyond the reach of most of their audiences or patients. Why then do they do it? I examine the logics and effects of their work to identify the forms of inclusion, care, efficacy, and explanation these open up. At the same time, I seek to discern the indirect effects of unequal access to knowledge and resources in the ambivalence, uncertainties, and contradictions that pervade these efforts to inform, diagnose, and advise.

show abstract

Section: Resultsmentioning

confidence: 99%

Filtering Inequality: Screening and Knowledge in Senegal’s Topography of Hepatitis B Care

Tousignant

2021

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

“…Its incidence remains considerable in endemic areas. It represents 5–10 % of all locations and 50–58 % of abdominal locations [ 4 ]. This form affects young adults between 20 and 40 years of age [ 7 ].…”

Section: Discussionmentioning

confidence: 99%

“…It ranks fourth after pulmonary, lymph node and osteoarticular tuberculosis, and is characterized by clinical and paraclinical diversity [ 3 ]. The incidence of peritoneal tuberculosis was estimated to be 50–58 % of abdominal locations [ 4 ]…”

Section: Introductionmentioning

confidence: 99%

Peritoneal tuberculosis, an underestimated diagnosis: a case report

Laamara,

Benaissa,

Achemlal

et al. 2024

Access Microbiology

View full text Add to dashboard Cite

Tuberculosis is an infectious disease that most often affects the lungs, caused by human-to-human transmission of Mycobacterium tuberculosis. Peritoneal tuberculosis is an extra-pulmonary form of the disease that usually manifests as an ascitic syndrome, with or without fever, in a context of altered general condition, often in endemic areas. The diagnosis of peritoneal tuberculosis is not always easy, as the clinical signs are often insidious and unspecific. We report a case of peritoneal tuberculosis in an 18-year-old female, who had presented for 10 days with a progressive increase in abdominal volume associated with vomiting and diarrhoea.

show abstract

“…Second, abdominal ultrasonography is useful in evaluating the therapeutic effects of the treatment of intestinal tuberculosis and tuberculous peritonitis. One study found that the abdominal ultrasonographic findings of 38 cases of tuberculous peritonitis revealed the involvement of the parietal peritoneum in 89.4%, ascites in 84.2%, anomalies of the greater omentum in 73.6%, and mesentery abnormalities in 63.1% of the patients [ 11 ]. In this case, all of these findings were confirmed at the onset of treatment and were consistent with the clinical diagnosis of tuberculous peritonitis.…”

Section: Discussionmentioning

confidence: 99%

Spontaneous Resolution of Strangulated Small Bowel Obstruction in a Patient With Intestinal Tuberculosis After Starting Anti-tuberculosis Drugs: A Case Report

Nakagawa¹,

Odaka²,

Yoshikawa³

et al. 2022

Cureus

View full text Add to dashboard Cite

Intestinal tuberculosis can cause strangulated small bowel obstruction. Strangulated small bowel obstruction usually requires surgery. We report a case of a patient with intestinal tuberculosis, who developed a spontaneously resolving strangulated small bowel obstruction after the commencement of antituberculosis drugs. A 72-year-old woman presented with abdominal pain and ascites was noticed on abdominal ultrasonography. Contrast-enhanced computed tomography (CT) revealed a 50-mm tumor in the ileocecal region that was darkly contrasted, along with peritoneal thickening and ascites. A malignant tumor and carcinomatous peritonitis were suspected. Colonoscopy showed an ulcerative lesion in the terminal ileum, and the acid-fast bacillus culture was positive; therefore, the patient was diagnosed with intestinal tuberculosis and was treated with isoniazid, rifampicin, ethambutol, and pyrazinamide. After commencing treatment, improvement in peritoneal thickening and ascites was confirmed using abdominal ultrasonography; therefore, we concluded that the ascites was due to tuberculous peritonitis. Six weeks after the initiation of treatment, the patient visited our facility with complaints of abdominal pain. Contrastenhanced CT revealed unenhanced small intestinal walls, and a diagnosis of strangulated small bowel obstruction was made; however, her symptoms improved naturally. Strangulated small bowel obstruction was presumed to be due to the presence of bands as anti-tuberculosis therapy could promote fibrosis. In this case, abdominal ultrasonography was useful in the evaluation of the effects of treatment.

show abstract

Ultrasonography of peritoneal tuberculosis

Cited by 11 publications

References 24 publications

Filtering Inequality: Screening and Knowledge in Senegal’s Topography of Hepatitis B Care

Filtering Inequality: Screening and Knowledge in Senegal’s Topography of Hepatitis B Care

Peritoneal tuberculosis, an underestimated diagnosis: a case report

Spontaneous Resolution of Strangulated Small Bowel Obstruction in a Patient With Intestinal Tuberculosis After Starting Anti-tuberculosis Drugs: A Case Report

Contact Info

Product

Resources

About